Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Small cell lung carcinoma].

J Gligorov1, C Couteau, P Debourdeau

  • 1Service d'oncologie médicale, hôpital Tenon, 4, rue de la Chine, 75970 Paris Cedex 20.

Bulletin Du Cancer
|December 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of combined trastuzumab-deruxtecan and concurrent radiation therapy in breast cancer. The TENDANCE multicentric French study.

Breast (Edinburgh, Scotland)·2025
Same author

Coupling of single nanodiamonds hosting SiV color centers to plasmonic double bowtie microantennas.

Nanotechnology·2025
Same author

Elacestrant in ESR1-mutant, endocrine-responsive metastatic breast cancer: should health authorities consider post hoc data to inform priority access?

ESMO open·2024
Same author

Causes, management, and prognosis of severe gastrointestinal bleedings in critically ill patients with pancreatic cancer: A retrospective multicenter study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2024
Same author

Prognostic value of comorbidities in older patients with cancer: the ELCAPA cohort study.

ESMO open·2023
Same author

Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program.

Oncogene·2023
Same journal

[ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

Bulletin du cancer·2026
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
See all related articles

Small cell lung carcinoma, a subset of lung cancer, has specific therapeutic strategies. This review covers its symptoms, outcomes, and the roles of chemotherapy, radiation, and surgery.

Area of Science:

  • Oncology
  • Pulmonology

Context:

  • Small cell lung carcinoma (SCLC) accounts for a minority of all lung cancer diagnoses.
  • Recent research has improved the understanding and treatment of SCLC.

Purpose:

  • To review the clinical presentation, treatment outcomes, and therapeutic roles in small cell lung carcinoma.
  • To consolidate current knowledge on chemotherapy, radiation therapy, and surgical interventions for SCLC.

Summary:

  • This review synthesizes information on the clinical symptoms associated with small cell lung carcinoma.
  • It examines the efficacy and application of chemotherapy, radiation therapy, and surgical options in managing SCLC.
  • Treatment results and the integrated roles of these modalities are discussed.

Impact:

Related Experiment Videos

  • Provides a comprehensive overview for clinicians managing small cell lung carcinoma.
  • Aids in understanding the multidisciplinary approach to SCLC treatment.
  • Contributes to evidence-based practice for lung cancer patients.